Arcxis Biotechnologies Garners Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=de667084-f6bc-4203-801f-49b28857c845&Preview=1 -
Date
1/30/2009 -
Company Name
Arcxis Biotechnologies -
Mailing Address
6920 Koll Center Parkway Pleasanton, CA 94566 -
Company Description
Arcxis Biotechnologies is a maker of laboratory systems for disease pathogen detection and clinical diagnostics. Headquarters are in Pleasanton, California. -
Website
http://www.arcxis.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Series B -
Proceeds Purposes
These funds will enable Arcxis to accelerate development, testing, and commercialization of their innovative nucleic acid sample preparation platform and their next generation sample to answer clinical molecular diagnostic platform. -
M&A Terms
-
Venture Investor
Claremont Creek Ventures -
Venture Investor
Kaiser Permanente Ventures -
Venture Investor
Alafi Capital
